DRUGS-ABOUT.COM

Pharmaceutical and healthcare online databases.
Over 200,000 approved drugs and health products.

Loading
Trade name of the product:
Quadracel
Pharmaceutical active ingredients:
  • Diphtheria Toxoid
  • Filamentous Haemagglutinin
  • Fimbriae
  • Pertactin
  • Pertussis Toxoid
  • Poliomyelitis (D.C.O.) Type 1 Mahoney Vaccine inactivated
  • Poliomyelitis (D.C.O.) Type 2 M.E.F.1 Vaccine inactivated
  • Poliomyelitis (D.C.O.) Type 3 Saukett Vaccine inactivated
  • Tetanus Toxoid
    • Available forms, composition and doses of Quadracel:
  • Injectable; Injection; Diphtheria Toxoid 15 LF; Filamentous Haemagglutinin 20 mcg; Fimbriae 5 mcg; Inactivated Poliomyelitis Vaccine (D.C.O.) Type 1 Mahoney 40 units; Inactivated Poliomyelitis Vaccine (D.C.O.) Type 2 M.E.F.1 8 units; Inactivated Poliomyelitis Vaccine (D.C.O.) Type 3 Saukett 32 units; Pertactin 3 mcg; Pertussis Toxoid 20 mcg; Tetanus Toxoid 5 LF / 0.5 ml
    • Medical categories:
  • Human:
  • Vaccines, antisera and immunologicals
    • Indications and usages, anatomical therapeutic chemical and diseases classification codes:
  • J07CA02 - Diphtheria-Pertussis-Poliomyelitis-Tetanus
    • Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers:
  • Sanofi-Aventis
  • Merck



    • Comments
    *Name:
    Email:
    Notify me about new comments on this page
    Hide my email
    *Text:
     

    Pharmaceutical Drugs | Health Products | Sitemap | New Products | About

    Copyright © 2005-2013 Drugs-about.com. All rights reserved.